retatrutide update october 2025 TikTok influencers fuelling parallel market for unlicensed weight-loss drug | Consumer affairs Retatrutide is the most significant
Description
Within dietary supplements, its share remains under 1%, while in functional foods and beverages, it accounts for less than 0.5%
The SELECT trial, completed in 2023 with over 17,600 participants, showed a 20% reduction in cardiovascular events in patients with established cardiovascular disease and overweight or obesity without diabetes
Select all that apply
Simental-Menda et al
